Routine vs. needed leg blood flow tube for heart pump patients
Part of Heart & circulation clinical trials.
This trial compares placing a small tube to keep blood flowing to the leg in all patients getting a heart pump versus only placing it when needed. It aims to prevent leg complications from the pump.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 or older.
- You have cardiogenic shock (heart isn't pumping enough blood) and need a heart pump placed through an artery in your groin.
- You can understand the risks and benefits of getting a leg blood flow tube, or a family member can agree for you.
- You do not have severe leg problems right after the pump is inserted.
- You do not have a bleeding disorder that makes procedures too risky.
- You are not pregnant, could become pregnant, or breastfeeding.
- You have not had certain leg bypass surgeries or a leg amputation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial studies whether an “early” or more “conservative” approach to improving blood flow to the leg can prevent limb damage during a type of heart-lung machine called peripheral VA-ECMO. It may help reduce the risk of poor leg blood flow (ischemia) in people with severe heart failure-related shock.
This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.